D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 53 Citations 15,263 146 World Ranking 1771 National Ranking 149

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Cancer

His primary areas of study are Intensive care medicine, Pharmacology, Internal medicine, Microbiology and Micafungin. His work carried out in the field of Intensive care medicine brings together such families of science as Clinical microbiology, Evidence-based medicine, Therapeutic drug monitoring and Drug resistance. His Pharmacology research integrates issues from Antifungal, Antifungal drug and Toxicity.

His Internal medicine study combines topics in areas such as Gastroenterology, Aspergillosis and Posaconazole. His research in Micafungin intersects with topics in Pharmacokinetics, Caspofungin, Echinocandins and Echinocandin. His Surgery study incorporates themes from Invasive fungal disease, Allergy and Fungal pneumonia.

His most cited work include:

  • Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group (3691 citations)
  • ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. (751 citations)
  • ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013 (543 citations)

What are the main themes of his work throughout his whole career to date?

William W. Hope spends much of his time researching Pharmacokinetics, Pharmacology, Pharmacodynamics, Internal medicine and Intensive care medicine. William W. Hope has researched Pharmacokinetics in several fields, including Dose, Drug, Liter and Dosing. His study on Pharmacology also encompasses disciplines like

  • Amphotericin B that connect with fields like Mycosis and Meningoencephalitis,
  • Micafungin and related Echinocandin, Caspofungin and Echinocandins.

The study incorporates disciplines such as Cryptococcus neoformans, Antibiotics, Drug resistance, Microbiology and Galactomannan in addition to Pharmacodynamics. His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology, Amphotericin B deoxycholate, Fluconazole and Surgery. His Intensive care medicine research incorporates elements of Antifungal, Antifungal drug, Aspergillosis and Transplantation.

He most often published in these fields:

  • Pharmacokinetics (47.41%)
  • Pharmacology (34.44%)
  • Pharmacodynamics (31.85%)

What were the highlights of his more recent work (between 2017-2021)?

  • Pharmacokinetics (47.41%)
  • Internal medicine (27.78%)
  • Pharmacodynamics (31.85%)

In recent papers he was focusing on the following fields of study:

William W. Hope mainly focuses on Pharmacokinetics, Internal medicine, Pharmacodynamics, Gastroenterology and Fluconazole. His Pharmacokinetics research is multidisciplinary, relying on both Liter, Dose, Dosing, Piperacillin and Drug. As a part of the same scientific family, William W. Hope mostly works in the field of Internal medicine, focusing on Amphotericin B deoxycholate and, on occasion, Interquartile range and Multicenter study.

His Pharmacodynamics study is related to the wider topic of Pharmacology. His Pharmacology study also includes fields such as

  • Antifungal, which have a strong connection to Healthy subjects,
  • In vivo, which have a strong connection to Galactomannan and Posaconazole. His Fluconazole research is multidisciplinary, incorporating elements of Amphotericin B, Cryptococcus, Isavuconazonium and Immunology.

Between 2017 and 2021, his most popular works were:

  • Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis (45 citations)
  • Prospective evaluation of poly-4-hydroxybutyrate mesh in CDC class I/high-risk ventral and incisional hernia repair: 18-month follow-up. (40 citations)
  • Generating Robust and Informative Nonclinical In Vitro and In Vivo Bacterial Infection Model Efficacy Data To Support Translation to Humans. (39 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Surgery
  • Cancer

His main research concerns Pharmacokinetics, Pharmacodynamics, Internal medicine, Antibiotic resistance and Fluconazole. Pharmacology covers William W. Hope research in Pharmacokinetics. His biological study spans a wide range of topics, including In vivo and Dosing.

William W. Hope interconnects Gastroenterology, Amphotericin B deoxycholate and Voriconazole in the investigation of issues within Internal medicine. His research on Antibiotic resistance also deals with topics like

  • Drug which connect with Pharmacotherapy, Intensive care medicine, Beta lactam antibiotics and Antimicrobial,
  • Multiple drug resistance which connect with Tebipenem, PK/PD models, Carbapenem and Klebsiella pneumoniae. His Fluconazole study combines topics in areas such as Meningitis, Cryptococcus, Amphotericin B and Combination therapy.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

Ben De Pauw;Thomas J. Walsh;J. Peter Donnelly;David A. Stevens.
Clinical Infectious Diseases (2008)

3691 Citations

ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

O.A. Cornely;M. Bassetti;T. Calandra;J. Garbino.
Clinical Microbiology and Infection (2012)

1024 Citations

Laboratory diagnosis of invasive aspergillosis

WW Hope;TJ Walsh;DW Denning.
Lancet Infectious Diseases (2005)

677 Citations

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

Johan A. Maertens;Issam I. Raad;Kieren A. Marr;Thomas F. Patterson.
The Lancet (2016)

605 Citations

ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013

O.A. Cornely;S. Arikan-Akdagli;E. Dannaoui;A.H. Groll.
Clinical Microbiology and Infection (2014)

543 Citations

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

Jason A Roberts;Jason A Roberts;Mohd H Abdul-Aziz;Jeffrey Lipman;Jeffrey Lipman;Johan W Mouton.
Lancet Infectious Diseases (2014)

535 Citations

Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology

H. Ruth Ashbee;Rosemary Ann Barnes;Elizabeth M. Johnson;Malcolm D. Richardson.
Journal of Antimicrobial Chemotherapy (2014)

433 Citations

EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)*

Maiken C. Arendrup;Manuel Cuenca-Estrella;Cornelia Lass-Flörl;William Hope.
Clinical Microbiology and Infection (2012)

404 Citations

Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation

Andreas H. Groll;Elio Castagnola;Simone Cesaro;Jean Hugues Dalle.
Lancet Oncology (2014)

373 Citations

ESCMID guideline for the diagnosis and management of Candida diseases 2012:diagnostic procedures

M. Cuenca-Estrella;P. E Verweij;M. C Arendrup;S. Arikan-Akdagli.
Clinical Microbiology and Infection (2012)

373 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing William W. Hope

Jason A. Roberts

Jason A. Roberts

Royal Brisbane and Women's Hospital

Publications: 219

Jeffrey Lipman

Jeffrey Lipman

Royal Brisbane and Women's Hospital

Publications: 179

Oliver A. Cornely

Oliver A. Cornely

University of Cologne

Publications: 151

Olivier Lortholary

Olivier Lortholary

Université Paris Cité

Publications: 142

Thomas J. Walsh

Thomas J. Walsh

Weill Cornell Medicine

Publications: 119

Paul E. Verweij

Paul E. Verweij

Radboud University Nijmegen

Publications: 115

Monica A. Slavin

Monica A. Slavin

Peter MacCallum Cancer Centre

Publications: 112

Dimitrios P. Kontoyiannis

Dimitrios P. Kontoyiannis

The University of Texas MD Anderson Cancer Center

Publications: 112

Sharon C.-A. Chen

Sharon C.-A. Chen

University of Sydney

Publications: 103

David W. Denning

David W. Denning

University of Manchester

Publications: 99

Matteo Bassetti

Matteo Bassetti

University of Genoa

Publications: 97

Patricia Muñoz

Patricia Muñoz

Hospital General Universitario Gregorio Marañón

Publications: 96

Maiken Cavling Arendrup

Maiken Cavling Arendrup

Statens Serum Institut

Publications: 94

Jacques F. Meis

Jacques F. Meis

Canisius-Wilhelmina Ziekenhuis

Publications: 92

Stéphane Bretagne

Stéphane Bretagne

Université Paris Cité

Publications: 91

Manuel Cuenca-Estrella

Manuel Cuenca-Estrella

Instituto de Salud Carlos III

Publications: 86

Trending Scientists

Wenxian Shen

Wenxian Shen

Auburn University

Mark Lundstrom

Mark Lundstrom

Purdue University West Lafayette

Seung-Ho Yu

Seung-Ho Yu

Korea University

Mark E. Ritchie

Mark E. Ritchie

Syracuse University

Hari C. Sharma

Hari C. Sharma

International Crops Research Institute for the Semi-Arid Tropics

Jan Tommassen

Jan Tommassen

Utrecht University

Ronald K.H. Liem

Ronald K.H. Liem

Columbia University

Yolanda Sáenz

Yolanda Sáenz

University of La Rioja

Greg Hirth

Greg Hirth

Brown University

Roland Maas

Roland Maas

University of Melbourne

P.M. van Bodegom

P.M. van Bodegom

Leiden University

Mark S. Goldman

Mark S. Goldman

University of South Florida

Catherine P. Bradshaw

Catherine P. Bradshaw

University of Virginia

Joseph P. Lynch

Joseph P. Lynch

University of California, Los Angeles

Sheila Sherlock

Sheila Sherlock

The Royal Free Hospital

Hidenori Arai

Hidenori Arai

Kyoto University

Something went wrong. Please try again later.